NCT05159427View on ClinicalTrials.gov

Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Human Gastrointestinal Physiology Data
Interventions
DRUG

Glucotrol XL 5Mg Extended-Release Tablet

Participants are randomized to take one tablet of this study drug by mouth.

DRUG

Glipizide ER 5 MG 24 HR Extended Release Oral Tablet

Participants are randomized to take one tablet of this study drug by mouth.

DRUG

Rifaximin 200Mg Tab

Participants will take one tablet of this study drug by mouth.

DRUG

13C6-Glipizide

Participants will take 1 mg of this study drug dissolved in 40 ml glucose solution by mouth.

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Michigan

OTHER